Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer : A feasibility study. / Lundorff, Lena ; Sjøgren, Per; Hansen, Ole Bo; Jonsson, Torsten; Nielsen, Per Rotbøll; Christrup, Lona Louring.

In: Journal of Opioid Management, Vol. 9, No. 4, 2013, p. 255-262.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lundorff, L, Sjøgren, P, Hansen, OB, Jonsson, T, Nielsen, PR & Christrup, LL 2013, 'Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study', Journal of Opioid Management, vol. 9, no. 4, pp. 255-262. https://doi.org/10.5055/jom.2013.0166

APA

Lundorff, L., Sjøgren, P., Hansen, O. B., Jonsson, T., Nielsen, P. R., & Christrup, L. L. (2013). Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study. Journal of Opioid Management, 9(4), 255-262. https://doi.org/10.5055/jom.2013.0166

Vancouver

Lundorff L, Sjøgren P, Hansen OB, Jonsson T, Nielsen PR, Christrup LL. Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study. Journal of Opioid Management. 2013;9(4):255-262. https://doi.org/10.5055/jom.2013.0166

Author

Lundorff, Lena ; Sjøgren, Per ; Hansen, Ole Bo ; Jonsson, Torsten ; Nielsen, Per Rotbøll ; Christrup, Lona Louring. / Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer : A feasibility study. In: Journal of Opioid Management. 2013 ; Vol. 9, No. 4. pp. 255-262.

Bibtex

@article{0ef307b968444685b4b159cf0d26a9c8,
title = "Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study",
author = "Lena Lundorff and Per Sj{\o}gren and Hansen, {Ole Bo} and Torsten Jonsson and Nielsen, {Per Rotb{\o}ll} and Christrup, {Lona Louring}",
year = "2013",
doi = "10.5055/jom.2013.0166",
language = "English",
volume = "9",
pages = "255--262",
journal = "Journal of Opioid Management",
issn = "1551-7489",
publisher = "Weston Medical Publishing, LLC",
number = "4",

}

RIS

TY - JOUR

T1 - Switching from high doses of pure u-opioid agonists to transdermal buprenorphine in patients with cancer

T2 - A feasibility study

AU - Lundorff, Lena

AU - Sjøgren, Per

AU - Hansen, Ole Bo

AU - Jonsson, Torsten

AU - Nielsen, Per Rotbøll

AU - Christrup, Lona Louring

PY - 2013

Y1 - 2013

U2 - 10.5055/jom.2013.0166

DO - 10.5055/jom.2013.0166

M3 - Journal article

VL - 9

SP - 255

EP - 262

JO - Journal of Opioid Management

JF - Journal of Opioid Management

SN - 1551-7489

IS - 4

ER -

ID: 80622028